| |
|
|
|
Neos Therapeutics Inc.  
|
|
0.6893 -0.008 (-0.01%) |
07-02 16:00 |
|
Open: |
0.69 |
Pre close: |
0.697 |
Target:
|
0.98
|
|
High: |
0.7099 |
Low: |
0.68 |
Resistance:
|
0.84
0.95
|
|
Volume: |
151,036 |
Market Cap: |
34M |
Support:
|
0.66
0.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.69
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
0.77 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.94 |
Stochastic Oscillator |
%K(14,3):
|
12.48  |
|
MA(250): |
1.32 |
%D(3): |
9.78 |
|
Average Volume(K) |
3-Month: |
18619
|
52-Week |
High:
|
2.15 |
|
10-Days: |
20064 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
39.71 |
Change(%): |
-50.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.347 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
49.75 |
|
EPS Est. Current Year |
-3.110 |
Return on Assets (ttm) |
-6.8 |
Shares Float (M) |
37.41 |
|
EPS Est. Next Year |
-1.440 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.83 |
|
EPS Est. Next Quarter |
-0.670 |
Qtrly Rev. Growth |
-1.0 |
% Held by Institutions |
42.90 |
|
Forward EPS |
-0.340 |
Gross Profit (p.s.) |
0.795 |
Shares Short (K) |
1260 |
|
Book Value (p.s.) |
-0.260 |
EBITDA (p.s.) |
-0.139 |
P/E |
-1.99 |
|
Sales Per Share |
1.297 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.65 |
|
Profit Margin |
-26.74 |
Operating Cash Flow
(M) |
-5.68 |
P/S |
0.53 |
|
Operating Margin |
-16.25 |
Levered Free Cash Flow
(M) |
-0.52 |
P/CF |
-6.04 |
|
|
|
|
|
|
